Colorectal cancer cases that are negative for CDX2 expression tend to be poorly differentiated tumours, and consistent with this finding, we observed that whereas 100% of well-differentiated tumours were CDX2 positive, only 58% of poorly differentiated tumours were CDX2 positive (Werling et al, 2003). This evidence concerns the gene CDX2 and colorectal cancer.